Price T Rowe Associates Inc. MD Has $37.42 Million Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Price T Rowe Associates Inc. MD lessened its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 36.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 583,147 shares of the company's stock after selling 327,976 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 0.22% of Ryan Specialty worth $37,416,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in RYAN. Mariner LLC increased its position in Ryan Specialty by 3.4% in the fourth quarter. Mariner LLC now owns 5,278 shares of the company's stock worth $339,000 after buying an additional 172 shares during the period. Sanctuary Advisors LLC lifted its position in Ryan Specialty by 1.2% in the 4th quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company's stock valued at $1,045,000 after purchasing an additional 188 shares during the last quarter. State of Alaska Department of Revenue grew its position in Ryan Specialty by 1.6% in the 4th quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company's stock worth $778,000 after purchasing an additional 190 shares during the last quarter. CIBC Asset Management Inc increased its stake in shares of Ryan Specialty by 5.6% in the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company's stock valued at $236,000 after purchasing an additional 196 shares during the period. Finally, Treasurer of the State of North Carolina raised its holdings in shares of Ryan Specialty by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 44,990 shares of the company's stock valued at $2,887,000 after buying an additional 280 shares during the last quarter. Institutional investors own 84.82% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on RYAN shares. Royal Bank of Canada reduced their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research report on Friday, February 21st. Wells Fargo & Company lowered their target price on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. TD Cowen began coverage on shares of Ryan Specialty in a research note on Thursday, April 10th. They issued a "buy" rating and a $89.00 price target for the company. Keefe, Bruyette & Woods lowered their price objective on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Finally, UBS Group upped their target price on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $75.67.

Ryan Specialty Stock Performance

Ryan Specialty stock traded up $0.66 on Monday, reaching $67.53. 171,482 shares of the stock were exchanged, compared to its average volume of 1,060,943. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a fifty day moving average price of $70.17 and a two-hundred day moving average price of $68.72. The stock has a market cap of $17.69 billion, a PE ratio of 97.87, a PEG ratio of 1.19 and a beta of 0.68. Ryan Specialty Holdings, Inc. has a twelve month low of $50.15 and a twelve month high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $0.39 EPS for the quarter, hitting the consensus estimate of $0.39. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The company had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. During the same period in the previous year, the business posted $0.35 EPS. The company's revenue for the quarter was up 25.0% on a year-over-year basis. Sell-side analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th will be given a $0.12 dividend. The ex-dividend date is Tuesday, May 13th. This represents a $0.48 annualized dividend and a yield of 0.71%. Ryan Specialty's dividend payout ratio is 141.18%.

Insider Transactions at Ryan Specialty

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 11.10% of the company's stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.